Is Parnell Pharmaceuticals Holdings Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Parnell Pharmaceuticals Holdings Ltd (PARNF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Parnell Pharmaceuticals Holdings Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Parnell Pharmaceuticals Holdings Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Parnell Pharmaceuticals Holdings Ltd?

Muslim investors may consider investing in Parnell Pharmaceuticals Holdings Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Parnell Pharmaceuticals Holdings Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Parnell Pharmaceuticals Holdings Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Parnell Pharmaceuticals Holdings Ltd updated?

The Shariah compliance status of Parnell Pharmaceuticals Holdings Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Parnell Pharmaceuticals Holdings Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Parnell Pharmaceuticals Holdings Ltd?

You can check the latest Shariah compliance status of Parnell Pharmaceuticals Holdings Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Parnell Pharmaceuticals Holdings Ltd. Stock Analysis PARNF

United States Health Care Nano Cap

Parnell Pharmaceuticals Holdings Ltd. is a veterinary pharmaceutical company, which engages in the development, manufacture, and commercialization of animal health solutions. The company is headquartered in Mascot, New South Wales. The company went IPO on 2014-06-18. The firm operates sterile manufacturing facilities and offers digital technology platforms that integrate with the Company’s products to offer veterinarians and animal owners superior solutions for their animal health needs. The firm also provides a fully integrated animal health platform. The Company’s mySYNCH is a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. The Company’s products include GONAbreed, estroPLAN, and RESPIRmycin. GONAbreed is used for the treatment of cystic ovaries and used in cattle synchronization protocols. The estroPLAN is used in animals with unobserved or non-detected estrus in cattle undergoing synchronization protocols. The RESPIRmycin is used for the treatment of respiratory disease in beef and non-lactating dairy cattle.

Key Statistics of Parnell Pharmaceuticals Holdings Ltd (PARNF)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.08AUD0.08

Today's Open

AUD0.08

Volume

100.00

P/E Ratio (TTM)

52 Week Range

AUD0.08AUD0.19

Market Cap

2.23M

Avg. Volume

8164.71

Dividend Yield

Financial Metrics & Statements of Parnell Pharmaceuticals Holdings Ltd (PARNF)

FAQ's for Parnell Pharmaceuticals Holdings Ltd (PARNF)

According to Musaffa’s Shariah screening methodology, Parnell Pharmaceuticals Holdings Ltd (PARNF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.